Back to funds

Sanofi

institutionalUpdated 17 days ago

Managed by Sanofi • Latest filing Q3 2026

Portfolio value
$629.9M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
156.9%
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$310.4M
Q1 2026$336M
Q2 2026$534M
Q3 2026$629.9M

Top holdings

16 positions as of Q3 2026

View filing
M

MeiraGTx Holdings plc

Unchanged
Value
$134.2M
Shares
12.20M
% Port
21.30%
I

Inhibrx Biosciences, Inc.

Unchanged
Value
$115.9M
Shares
1.16M
% Port
18.40%
N
Unchanged
Value
$74.4M
Shares
6.88M
% Port
11.81%
?
4.N/A

Korsana Biosciences

Value
$63.8M
Shares
1.99M
% Port
10.13%
O

Odyssey Therapeutics Inc.

-0.1%
Value
$44.2M
Shares
1.99M
% Port
7.02%
A

AnaptysBio

Unchanged
Value
$41.3M
Shares
821.9K
% Port
6.56%
A

Agomab Therapeutics NV

Unchanged
Value
$30.9M
Shares
2.78M
% Port
4.90%
?
8.N/A

First Tracks Biotherapeutics Inc.

Unchanged
Value
$29.1M
Shares
821.9K
% Port
4.62%
?
9.N/A

Electra Therapeutics Inc

Value
$27.7M
Shares
2.46M
% Port
4.40%
?
10.N/A

Attovia Therapeutics Inc

Value
$18.6M
Shares
1.08M
% Port
2.95%
?
11.N/A

Latigo Biotherapeutics Inc

Value
$11.2M
Shares
672.8K
% Port
1.78%
I

Immuneering Corp

Unchanged
Value
$11.1M
Shares
2.71M
% Port
1.76%
M

MapLight Therapeutics Inc.

Unchanged
Value
$9.3M
Shares
912.0K
% Port
1.48%
?
14.N/A

Scribe Therapeutics

Value
$9.2M
Shares
500.0K
% Port
1.46%
S

SAB BIOTHERAPEUTICS INC

Value
$7M
Shares
2.20M
% Port
1.11%
Q

Q32 Bio Inc.

Unchanged
Value
$2M
Shares
244.1K
% Port
0.32%

Explore